Nextage Therapeutics (XTAE:NXTG) Other Net Income (Loss) : ₪0.00 Mil (TTM As of Jun. 2024)

View and export this data going back to 1993. Start your Free Trial

What is Nextage Therapeutics Other Net Income (Loss)?

Nextage Therapeutics's Other Net Income (Loss) for the six months ended in Jun. 2024 was ₪0.00 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Jun. 2024 was ₪0.00 Mil.

Nextage Therapeutics's quarterly Other Net Income (Loss) declined from Jun. 2023 (₪0.00 Mil) to Dec. 2023 (₪0.00 Mil) but then stayed the same from Dec. 2023 (₪0.00 Mil) to Jun. 2024 (₪0.00 Mil).

Nextage Therapeutics's annual Other Net Income (Loss) increased from Dec. 2021 (₪0.00 Mil) to Dec. 2022 (₪0.00 Mil) but then declined from Dec. 2022 (₪0.00 Mil) to Dec. 2023 (₪0.00 Mil).

Nextage Therapeutics Other Net Income (Loss) Historical Data

The historical data trend for Nextage Therapeutics's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nextage Therapeutics Other Net Income (Loss) Chart

Nextage Therapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Net Income (Loss)

Get a 7-Day Free Trial

Nextage Therapeutics Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Other Net Income (Loss)	Get a 7-Day Free Trial										-	-	-	-	-

Nextage Therapeutics Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₪0.00 Mil.

Nextage Therapeutics Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Nextage Therapeutics's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Nextage Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nextage Therapeutics Ltd (XTAE:NXTG) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

N/A

Address

Bio-Light, Kiryat Atidim 7, Entrance 1, 2rd Floor, Tel Aviv, ISR, 61581

Website

http://www.m-medic.com

Nextage Therapeutics Ltd is a holding company. The company, through its subsidiaries, is engaged in the development of biological marker, a molecule/gene, which when present in the body at abnormal levels indicates development of a disease. It is focused on the development and commercialization of cancer diagnostic products.

Nextage Therapeutics Headlines

From GuruFocus

First Trust Global Portfolios Limited Announces Name Changes for Certain Sub-Funds of First Trust Global Funds plc

By Business Wire Business Wire • 01-29-2021